Health
Psychedelic therapy yields opposite outcomes, challenges treatment protocols
Psychedelic therapy yields opposite outcomes, healing some while deeply unsettling others, challenging health protocols…
James Whitfield·
5 articles
Psychedelic therapy yields opposite outcomes, healing some while deeply unsettling others, challenging health protocols…
CSPC Pharmaceutical’s SYH2059 KAT6 inhibitor receives FDA approval for clinical trials in the U.S., marking a significan…
The NFID confirms the vaccine trial gold standard is a long-standing practice, not new, reinforcing trust in vaccine saf…
FDA clears an investigational new drug application for sCAR-T therapy for autoimmune conditions, marking a groundbreakin…
Psychedelic clinical trials are facing unforeseen hurdles despite their leap from counterculture to clinical focus. Lear…